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One hundred clinical isolates from a prospective na-
tionwide study of scedosporiosis in Australia (2003–2005) 
and 46 additional isolates were genotyped by internal tran-
scribed spacer–restriction fragment length polymorphism 
(ITS-RFLP) analysis, ITS sequencing, and M13 PCR ﬁ  nger-
printing. ITS-RFLP and PCR ﬁ  ngerprinting identiﬁ  ed 3 dis-
tinct genetic groups. The ﬁ  rst group corresponded to Sce-
dosporium proliﬁ  cans (n = 83), and the other 2 comprised 
isolates previously identiﬁ  ed  as  S. apiospermum: one of 
these corresponded to S. apiospermum (n = 33) and the 
other to the newly described species S. aurantiacum (n = 
30). Intraspecies variation was highest for S. apiospermum 
(58%), followed by S. proliﬁ  cans (45%) and S. aurantiacum 
(28%) as determined by PCR ﬁ  ngerprinting. ITS sequence 
variation of 2.2% was observed among S. apiospermum iso-
lates. No correlation was found between genotype of strains 
and their geographic origin, body site from which they were 
cultured, or colonization versus invasive disease. Twelve S. 
proliﬁ  cans isolates from 2 suspected case clusters were ex-
amined by ampliﬁ  ed fragment length polymorphism analy-
sis. No speciﬁ  c clusters were conﬁ  rmed.
D
espite efforts to identify and eliminate infectious 
agents, they continue to emerge and reemerge (1). 
Among them, pathogenic fungi contribute substantially 
to illness and death, especially in immunocompromised 
patients (2,3). In contrast to the well-documented oppor-
tunists Candida albicans, Cryptococcus neoformans, and 
Aspergillus fumigatus, the epidemiology and evolution 
of human infections caused by uncommon but emerging 
fungi are incompletely understood. Such pathogens include 
Scedosporium apiospermum (teleomorph Pseudallescheria 
boydii) and S. proliﬁ  cans, which are inherently resistant to 
many antifungal agents (3–5).
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S. apiospermum infections occur worldwide, ranging 
from localized mycetomas to deep-seated disease such as 
cerebral abscesses (6,7). This species also colonizes the re-
spiratory tract of ≈10% of patients with cystic ﬁ  brosis and 
chronic suppurative lung disease (8–10). On the basis of 
genetic data, a new species, S. aurantiacum, was proposed 
for a subset of isolates previously identiﬁ  ed as S. apiosper-
mum (11). S. proliﬁ  cans infections are geographically more 
restricted than those caused by S. apiospermum, being 
most prevalent in Australia, Spain, and the United States 
(12–15). S. proliﬁ  cans typically causes localized infections 
in immunocompetent hosts but rapidly fatal disseminated 
infections in the immunocompromised among whom it has 
been associated with nosocomial outbreaks (3,12–17). 
Since scedosporiosis, in particular that caused by S. 
proliﬁ  cans, is often refractory to treatment (3,5), preven-
tive strategies are of paramount importance. However, the 
epidemiology and mode of transmission of infection are not 
well understood. Furthermore, the environmental reservoir 
of S. proliﬁ  cans is unknown. Molecular typing techniques 
now provide the means to elucidate the epidemiology of 
Scedosporium infections and to investigate potential case 
clusters (16,18,19). Strains recovered from patients with 
cystic ﬁ  brosis have demonstrated a high degree of genetic 
variability (10,20), although a single genetic proﬁ  le pre-
dominated in 1 study (8). The degree of genetic variation 
within S. proliﬁ  cans is more controversial. Two studies 
have reported low to no intraspecies genetic heterogene-
ity (16,21), while a third noted substantial genetic diversity 
(19). The results of these studies may be biased because 
they included only small numbers of isolates from speciﬁ  c 
patient populations. Genetic variability among S. aurantia-
cum has not yet been studied.
In this study, we used 4 molecular tools to examine 
genetic variation among a large number of Australian clini-
cal Scedosporium isolates: 1) internal transcribed spacer 
(ITS)–based restriction fragment length polymorphism 
(ITS-RFLP) analysis; 2) DNA sequence analysis of the ITS 
region (selected isolates); 3) PCR ﬁ  ngerprinting using the 
microsatellite speciﬁ  c core sequence of phage M13; and 4) 
ampliﬁ  ed fragment length polymorphism (AFLP) analysis 
(isolates from suspected case clusters). We also searched 
for the newly described species, S. aurantiacum and for 
genetic clustering of strains according to their geographic 
origin, body site from which they were cultured, and ability 
to cause invasive disease.
Materials and Methods
Scedosporium Isolates and Data Collection
A total of 146 Scedosporium isolates were studied 
(online Technical Appendix, available from www.cdc.
gov/EID/content/14/2/282-Techapp.pdf). Forty-six were 
from the culture collection at the Clinical Mycology Labo-
ratory, Centre for Infectious Diseases and Microbiology 
Laboratory Services, Westmead Hospital, Sydney, Austra-
lia. For these isolates, the following data were captured: 
demographic information, patient coexisting conditions 
and risk factors (summarized in the online Technical Ap-
pendix). The remaining 100 isolates were obtained through 
a national, prospective, laboratory-based surveillance for 
scedosporiosis in Australia (the Australian Scedosporium 
[AUSCEDO] Study) from January 2003 to December 
2005. The following data were collected: clinical status, 
risk factor (deﬁ  ned according to published risk factors for 
scedosporiosis [4,12–15]), major comorbidity (based on the 
International Classiﬁ  cation of Diseases, 10th revision, Aus-
tralian Modiﬁ  cation [ICD-10 AM] diagnostic classiﬁ  cation 
system [22]), isolated species, treatment and outcome. Sce-
dosporium strains obtained from a single colony from the 
primary isolation plate from all patients were forwarded 
to the Molecular Mycology Research Laboratory, West-
mead Hospital, for genotyping. Isolates were identiﬁ  ed as 
S. proliﬁ  cans or S. apiospermum by standard phenotypic 
methods (23). Species were conﬁ  rmed as S. proliﬁ  cans or 
S. apiospermum, and S. aurantiacum was identiﬁ  ed (11) by 
ITS-RFLP analysis.
Deﬁ  nitions
An episode of scedosporiosis was deﬁ  ned as the in-
cident isolation of Scedosporium spp. from any body site. 
Two or more episodes, fulﬁ  lling the case deﬁ  nition and 
occurring in different patients that were epidemiologically 
linked were deﬁ  ned as a potential case cluster. Invasive dis-
ease was deﬁ  ned according to the European Organization 
for Treatment of Cancer/Mycoses Study Group criteria for 
“deﬁ  nite” or “probable” infection (24). All other patients 
not fulﬁ  lling these criteria, including those with “possible” 
infection were considered colonized. Coincident hospital 
renovations or construction was considered to be a potential 
risk factor if major work was undertaken within 3 months 
before the isolation of Scedosporium spp. from a patient.
Description of 2 Potential Case Clusters
The ﬁ  rst potential case cluster involved 8 patients lo-
cated in the same hematology/hemopoietic stem cell trans-
plant (HSCT) unit at the Alfred Hospital, a large university 
hospital in Melbourne (September 2000–October 2001; 
[15]). The second consisted of 3 patients located in the 
same hematology/HSCT ward at Westmead Hospital a ma-
jor university hospital in Sydney (September 2003–January 
2004; unpub. data). Details of the patients involved in these 
suspected case clusters are summarized in the online Tech-
nical Appendix). On each occasion, patient isolates were 
submitted for genetic analyses to inform infection control 
responses (see Results).
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Genomic DNA Extraction and ITS-RFLP Analysis
Genomic DNA was isolated as described previously 
(18). The ITS1, 5.8S, and ITS2 regions of the rDNA gene 
cluster were ampliﬁ  ed with the primers SR6R and LR1 (Ta-
ble 1) as described previously (25). Amplicons were double 
digested with the restriction endonucleases Sau96I and HhaI 
(New England BioLabs, Ipswich, MA, USA) in accordance 
with the manufacturer’s recommendations. Digested prod-
ucts were separated by electrophoresis in 3% agarose gels at 
100 V for 3–4 h. Banding patterns were analyzed visually.
ITS Sequencing
Eleven isolates, representative of each of 3 ITS-RFLP 
patterns obtained, were selected for ITS sequencing: ITS-
RFLP proﬁ  le A (S. proliﬁ  cans, WM 06.378, WM 06.440, 
and WM 06.393), ITS-RFLP proﬁ  le B (S. apiospermum, 
WM 06.389, WM 06.471, and WM 06.497), and ITS-RFLP 
proﬁ  le C (S. aurantiacum, WM 06.388, WM 06.482, WM 
06.495, WM 06.496, and WM 06.498). The ITS region was 
ampliﬁ  ed as described above and commercially sequenced 
in both directions by using SR6R or LR1 (Table 1) as for-
ward and reverse primers.
PCR Fingerprinting
The minisatellite-speciﬁ  c core sequence of the wild-
type phage M13 was used as a single primer for PCR ﬁ  nger-
printing (Table 1). Ampliﬁ  cation reactions were performed 
as previously described (18). Blank control tubes containing 
all reagents except template DNA were included for each 
run; each sample was analyzed at least twice. PCR products 
were separated by electrophoresis on 1.4% agarose gels at 
60 V for 14 cm. Strains were deﬁ  ned to be identical if their 
PCR ﬁ  ngerprinting proﬁ  les had a similarity of >97% ( = 1 
band difference). Reproducibility of the PCR ﬁ  ngerprinting 
technique was accessed by re-amplifying 1 strain of each of 
the 3 Scedosporium spp. with all PCR ampliﬁ  cations car-
ried out and re-running those on each gel.
AFLP Analysis
AFLP analysis was performed as described previously 
by using either EcoRI-GT 6-FAM-labeled and MseI-GT 
or  EcoRI-TC 6-FAM-labeled and MseI-CA as selective 
primer pairs (QIAGEN, Valencia, CA, USA; Table 1) (26). 
All samples were analyzed by using the ABI Prism 3730 
system (Applied Biosystems, Foster City, CA, USA). Data 
collation, fragment sizing, and pattern analyses were per-
formed with GeneMapper software version 3.5 (Applied 
Biosystems). Only electrophoregram peaks above 1,000 
ﬂ  uorescent units were scored for the presence or absence 
of bands of the same size (range 50–500 bp) relative to the 
GeneScan 500 LIZ DNA size standard (Applied Biosys-
tems). Only bands detected in duplicate AFLP experiments 
were included in the analysis.
Data Analysis
Clinical Data
Statistical analysis was performed by using SPSS ver-
sion 10.0.07 (SPSS, Chicago, IL, USA) and EpiInfo ver-
sion 6.0 (Centers for Disease Control and Prevention, At-
lanta, GA, USA). Proportions were compared by using the 
χ2 or Fisher exact test. A p value <0.05 was statistically 
signiﬁ  cant.
ITS Sequences
ITS sequences obtained from 11 isolates (see above) 
were aligned with the ITS sequences of the following refer-
ence strains obtained from GenBank: S. apiospermum CBS 
101.22 (accession no. AJ888435), S. aurantiacum FMR 
8630 (accession no. AJ888440), S. aurantiacum IHEM 
15458 (accession no. AJ888441) and S. proliﬁ  cans CBS 
114.90 (accession no. AY882369) as well as 2 outgroup 
sequences: Pseudallescheria africana CBS 311.72 (acces-
sion no. AJ888425), and Petriella setifera CBS 164.74 (ac-
cession no. AY882352). Phylogenetic analyses were per-
formed by using PAUP* version 4.06.10 (27).
PCR Fingerprinting Patterns and AFLP Fragments
PCR ﬁ  ngerprinting patterns were analyzed by using 
the 1D gel analysis module (BioGalaxy  [BioAware, Han-
nut, Belgium]) in BioloMICS version 7.5.30 (BioAware). 
Images were normalized for lane to-lane differences in 
mobility by the alignment of patterns obtained on multi-
ple loadings of the 1kb DNA size marker (GIBCO-BRL, 
Gaithersburg, MD, USA). The unweighted-pair group 
method by using arithmetic averages and the procedures 
of Nei and Li (28), both implemented in BioloMICS, were 
used to generate dendograms based on the coefﬁ  cient of 
similarity (29) between the isolates. In addition, principal 
coordinate analysis (PcoA; BioloMICS) was conducted to 
give an overall representation of the observed strain varia-
tion. AFLP fragments were analyzed with BioloMICS.
Results
A total of 146 Scedosporium isolates from 120 epi-
sodes (119 patients) were studied (online Technical Ap-
pendix). Demographic data were available for 108 (90%) 
episodes and coexisting conditions and risk factor data for 
115 (95.8%). Most episodes were reported from New South 
Wales (64.2%), followed by Victoria (19.2%) and Western 
Australia (9.2%). The male: female ratio was 1.3: 1. The 
major patient coexisting conditions and known risk factors 
for scedosporiosis are summarized in the online Technical 
Appendix. Thirty-nine patients (32.7%) had no underlying 
medical condition. Coincident building construction was 
noted in 27 cases (22.5%). Scedosporium isolates were 
associated with invasive disease in 46 (38.3%) instances; 
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the remaining 74 (61.7%) were isolated from patients who 
were colonized (Table 2).
Molecular Typing of Scedosporium Isolates
All 146 isolates were examined by ITS-RFLP analy-
sis and PCR ﬁ  ngerprinting. ITS sequencing was performed 
on 11 strains as described above. AFLP analysis was per-
formed only for selected S. proliﬁ  cans isolates, including 
the isolates of the suspected case clusters and isolates rep-
resentative of the S. proliﬁ  cans branches identiﬁ  ed by PCR 
ﬁ  ngerprinting (online Appendix Figure 1, available from 
www.cdc.gov/EID/content/14/2/282-appG1.htm). 
ITS-RFLP Analysis
RFLP analysis found 1 RFLP proﬁ  le speciﬁ  c for S. 
proliﬁ  cans isolates (ITS-RFLP proﬁ  le A) and 2 proﬁ  les 
(ITS-RFLP proﬁ  les B and C) for isolates previously phe-
notypically identiﬁ  ed as S. apiospermum (Figure 1, panel 
A). ITS-RFLP proﬁ  le B corresponded to S. apiospermum 
and ITS-RFLP proﬁ  le C to the newly described species, S. 
aurantiacum.
ITS Sequencing
Sequencing of the ITS 1, 5.8S, and ITS2 regions of the 
11 strains, representative of each of the 3 ITS-RFLP pro-
ﬁ  les found the following results: BLAST searches against 
the corresponding GenBank reference sequences identi-
ﬁ  ed strains: WM 06.389 (accession no. EF639870), WM 
06.497 (accession no. EF639872), and WM 06.471 (acces-
sion no. EF639871) (ITS-RFLP proﬁ  le B) as S. apiosper-
mum (96%–99% sequence similarity to strain CBS 101.22). 
Strains WM 06.388 (accession no. EF639865), WM 06.482 
(accession no. EF639866), WM 06.495 (accession no. 
EF639867), WM 06.496 (accession no. EF639868), and 
WM 06.498 (accession no. EF639869) (ITS-RFLP pro-
ﬁ  le C) were identiﬁ  ed as S. aurantiacum (100% sequence 
identity with strains FMR 8630 and IHEM 15458). Isolates 
WM 06.393 (accession no. EF639863), WM 06.440 (ac-
cession no. EF639864) and WM 06.378 (accession no. 
EF639862) (ITS-RFLP proﬁ  le A) were identiﬁ  ed as S. pro-
liﬁ  cans (100% identity with strain CBS 114.90).
Phylogenetic analysis of the sequences demonstrated 
3 distinct clades, the ﬁ  rst corresponding to S. proliﬁ  cans 
as the basal clade. The other 2 corresponded to the 2 more 
closely related but clearly distinct clades, S. apiosper-
mum, and S. aurantiacum (Figure 2). S. apiospermum 
showed intraspecies sequence variation of 2.2% compared 
to S. aurantiacum and S. proliﬁ  cans, which displayed no 
variation.
Final Identiﬁ  cation of Scedosporium spp. 
and Clinical Associations
S. proliﬁ  cans accounted for 75 patient episodes (83 of 
146 isolates; 56.9%), S. apiospermum for 25 (33 isolates; 
22.6%), and S. aurantiacum for 23 (30 isolates; 20.6%) 
(online Technical Appendix). More than 1 Scedosporium 
spp. was isolated from the same patient in 3 instances: Pa-
tient 83: S. apiospermum (WM 06.471, WM 06.472, WM 
06.474, and WM 06.475) and S. proliﬁ  cans (WM 06.473); 
patient 91: S. apiospermum (WM 06.486) and S. proliﬁ  -
cans (WM 06.485); and patient 102: S. apiospermum (WM 
06.500) and S. proliﬁ  cans (WM 06.501) (online Techni-
cal Appendix). In 6 episodes, the same species was recov-
ered from more than 1 body site in the same patient at the 
same time (patients 57 [blood, bronchial washing, skin], 73 
[blood, sputum], 80 [sputum, bone, wound ﬂ  uid], 83 [bron-
chial washing, bronchoalveolar lavage], 118 [pleural ﬂ  uid, 
bone, wound ﬂ  uid, chest tissue], and 119 [blood, skin]; on-
line Technical Appendix).
Approximately half (40%–52.2%) of S. apiospermum 
and S. aurantiacum isolates were from the respiratory tract/
lung compared to 20% for S. proliﬁ  cans. Conversely, all 
isolates from blood, 57.2% isolates from skin/soft tissue 
and 66.7% from eye were S. proliﬁ  cans (Table 2). Inva-
sive disease was more likely to be caused by S. proliﬁ  cans 
than non-proliﬁ  cans Scedosporium spp. (83% versus 17% 
of isolations; odds ratio (OR) 5.3, 95% conﬁ  dence interval 
(CI) 2.0, 14.2, p = 0.002) (Table 2). This association was 
signiﬁ  cant when compared with S. apiospermum as well as 
with S. aurantiacum (p<0.05; data not shown). The relative 
proportions of invasive disease among S. apiospermum and 
S. aurantiacum were similar (Table 2). Coincident build-
ing construction (27 cases, 22.5%) was more likely to be 
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Table 1. Primer and adaptor oligonucleotide sequences used in 
the study 
Primer or adaptor 
oligonucelotide Sequence (5′→3′)
rDNA primers 
 SR6R  AAGTARAAGTCGTAACAAGG 
 LR1  GGTTGGTTTCTTTTCCT 
M13 fingerprinting primer 
  Phage M13  GAGGGTGGCGGTTCT 
EcoRI adapters 
 EA1  CTCGTAGACTGCGTACC 
 EA2  CATCTGACGCATGGTTAA 
Msel adapters 
 MA1  GACGATGAGTCCTGAG 
 MA2  TACTCAGGACTCAT 
Preselective primers 
 EcoRI-T GACTGCGTACCAATTCT 
 EcoRI-G GACTGCGTACCAATTCG 
 Msel-C GATGAGTCCTGAGTAAC 
 Msel-G GATGAGTCCTGAGTAAG 
Selective primers 
 EcoRI-TG 6 FAM-GACTGCGTACCAATTCTG 
 EcoRI-GT 6 FAM-GACTGCGTACCAATTCGT 
 Msel-CA GATGAGTCCTGAGTAACA 
 Msel-GT GATGAGTCCTGAGTAAGT RESEARCH
associated with isolation of S. proliﬁ  cans compared with 
non-proliﬁ  cans Scedosporium spp. (OR 11.5, 95% CI 2.4, 
74.5; p<0.001; data not shown).
Molecular Epidemiology
Strain Typing
PCR ﬁ  ngerprinting delineated 3 major clusters concor-
dant with S. apiospermum, S. aurantiacum, and S. proliﬁ  -
cans (online Appendix Figure 1; Figure 1, panel B; Figure 
3). Clusters corresponding to S. aurantiacum and S. proliﬁ  -
cans were substantially more densely grouped than the S. 
apiospermum cluster (Figure 3).
PCR  ﬁ  ngerprinting  proﬁ   les showed polymorphisms 
within each of the 3 species, allowing for a clear differen-
tiation, by using a “cut-off point” of  >97% similarity. Mul-
tiple isolates from the same patient obtained from different 
anatomic sites (online Technical Appendix) had identical 
or >97% similarity between their PCR ﬁ  ngerprints, except 
for 1 patient (patient 118). In 8 instances, PCR ﬁ  ngerprint-
ing showed that patients were infected with 2 different 
strains: (patients 1, 10, 27, 57, 83 99, 118 [online Appen-
dix Figure 1, online Technical Appendix]). For all species, 
genetic proﬁ   les were independent of geographic origin, 
body site of isolation or whether the patient was infected 
or colonized (online Appendix Figure 1). Proﬁ  les were also 
independent of patient comorbidityity and risk factors for 
scedosporiosis (data not shown). Intraspecies PCR ﬁ  nger-
printing variation was highest for S. apiospermum (58%) 
followed by S. proliﬁ  cans (45%) and S. aurantiacum (28%) 
(online Appendix Figure 1).
Examination of Isolates from 
Suspected Case Clusters
Twelve isolates from 2 presumptive case clusters of 
S. proliﬁ  cans infection (Alfred Hospital, Melbourne pa-
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Figure 1. Internal transcribed spacer–restriction fragment length 
polymorphism (ITS-RFLP) patterns obtained by double digestion 
with the enzymes Sau96I and HhaI (A) and of the PCR ﬁ  ngerprinting 
proﬁ  les obtained with the microsatellite speciﬁ  c primer M13 (B) for 
Scedosporium proliﬁ  cans: lane 1, WM 06.457; lane 2, WM 06.458; 
lane 3, WM 06.503; lane 4, WM 06.502; lane 5, WM 06.399; lane 
6, WM 06.434. S. aurantiacum: lane 7, WM 06.495; lane 8, WM 
06.496; lane 9, WM 06.386; lane 10, WM 06.385; lane 11, WM 
06.482; lane 12, WM 06.390. S. apiospermum: lane 13, WM 
06.475; lane 14, WM 06.474; lane 15, WM 06.472; lane 16, WM 
06.471; lane 17, WM 06.424; lane 18, WM 06.443; lane M, 1-kb 
marker (GIBCO-BRL, Gaithersburg, MD, USA).
Figure 2. Rooted phylogram (outgroup Pseudallescheria africana 
CBS 311.72 and Petriella setifera CBS 164.74), showing the 
relationships among 11 selected strains representing each obtained 
internal transcribed spacer (ITS)–restriction fragment length 
polymorphism pattern and 4 reference strain sequences obtained 
from GenBank by using PAUP* version 4.06.10 (29). Scedosporium Isolates, Australia
tients: isolates WM 06.392, WM 06.393, WM 06.395, 
WM 06.399, WM 06.400, WM 06.401, WM 06.402, and 
WM 06.405; Westmead Hospital, Sydney patients: isolates 
WM 06.432, WM 06.434, WM06.457, and WM 06.458; 
online Technical Appendix) as well as 23 additional iso-
lates, representative of the S. proliﬁ  cans branches iden-
tiﬁ  ed by PCR ﬁ  ngerprinting (online Appendix Figure 1) 
were further investigated by AFLP typing. S. proliﬁ  cans 
was not isolated from the environment in either setting 
despite extensive sampling. The AFLP bands were found 
to be 50–493 bp by using the primers EcoRI-GT and 
MseI-GT (data not shown), and from 52–468 bp by using 
the primers EcoRI-TG and MseI-CA (online Appendix 
Figure 2, available from www.cdc.gov/EID/content/14/2/
282-appG2.htm). These 35 isolates exhibited 32 different 
AFLP proﬁ  les, with isolates from the same patient (pa-
tients 1, 73, and 119) showing identical proﬁ  les (online 
Appendix Figure 2), conﬁ  rming the PCR ﬁ  ngerprinting 
results (online Appendix Figure 1). PcoA of the combined 
AFLP and PCR ﬁ  ngerprinting data demonstrated no clus-
tering of these isolates (Figure 4), which ruled out the 
possibility of nosocomial transmission.
Discussion
We examined genetic variation among a large num-
ber of population-derived Scedosporium isolates across the 
Australian continent. In line with previously reported ge-
netic variability in the S. apiospermum/P. boydii species 
complex (30–32), we observed 2 distinct ITS-RFLP pat-
terns among S. apiospermum isolates, showing the pres-
ence of the newly described species S. aurantiacum (11). 
Notably, we have identiﬁ  ed by ITS sequencing that S. au-
rantiacum comprised 45% of the current collection of Aus-
tralian “S. apiospermum” isolates and documents genetic 
variability within S. aurantiacum.
Epidemiologic investigation of Scedosporium infec-
tion requires accurate identiﬁ  cation and typing. S. apio-
spermum, S. aurantiacum, and S. proliﬁ  cans were clearly 
distinguished from each other by PCR ﬁ  ngerprinting and 
ITS-RFLP analysis. This is consistent with previous rDNA 
sequence-based studies (30,33,34). The observation of 2 
distinct genetic groups, corresponding to S. aurantiacum 
and S. apiospermum, supports the proposal that S. auran-
tiacum be designated a separate species (11). This proposal 
is also supported by the 5%–10% ITS sequence variation 
found between S. aurantiacum and S. apiospermum com-
pared to an absence of intraspecies variation in S. aurantia-
cum and S. proliﬁ  cans and a 2.2% variation in S. apiosper-
mum (30,32; current study).
Using PCR ﬁ  ngerprinting, intraspecies variation was 
greatest (58%) among S. apiospermum isolates (Figure 
3). This diversity is generally consistent with the high 
degree of polymorphism (15–20 genotypes) previously 
found (10,20,32). In contrast, genetic variation was lowest 
(28%) among the S. aurantiacum isolates (online Appen-
dix Figure 1; Figure 3). Nevertheless, PCR ﬁ  ngerprinting 
polymorphisms clearly differentiated all 30 strains (online 
Appendix Figure 1). Further genotyping studies of a greater 
number of and more geographically diverse S. aurantiacum 
isolates are warranted.
The intraspecies PCR ﬁ  ngerprint variation in S. pro-
liﬁ  cans (45%) was greater than that in S. aurantiacum but 
less than that in S. apiospermum. Given that S. aurantia-
cum is phylogenetically more closely related to S. apio-
spermum than to S. proliﬁ  cans (11,33; current study), this 
result was unexpected. It may be due to different evolu-
tionary pressures acting on the 3 different species or the 
relatively small numbers of S. aurantiacum isolates studied 
to date. The moderate genetic diversity among S. proliﬁ  -
cans conﬁ  rms previous ﬁ  ndings (19). Despite the observed 
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Table 2. Selected characteristics for 120 isolations (episodes) of Scedosporium spp. 
Characteristic*
No.Scedosporium prolificans; 
n = 75 (%)† 
No. S. apiospermum; 
 n = 25 (%)† 
No. S. aurantiacum;
n = 23 (%)† 
Male sex  40 (53.3)  12 (48)  8 (34.8) 
Risk factor 
 Surgery   30 d  3 (4)  1 (4)  –
  Trauma  5 (6.7)  – 1 (4.4) 
Clinical status‡ 
  Invasive disease  39 (52)  4 (16)  4 (17.4) 
  Colonization  36 (48)  21 (84)  19 (82.6) 
Body site of isolation 
 Blood  18  (24)  – –
  Eye  2 (2.7)  – 1 (4.4) 
  Skin/soft tissue  4 (5.3)  1 (4)  2 (8.7) 
  Lung/respiratory tract  15 (20)  10 (40)  12 (52.2) 
  Ear  4 (5.3)  10 5 (21.2) 
*Some patients had Scedosporium isolated from more than 1 body site. 
†Refers to no. episodes in which each species was isolated. The total no. of isolates was 146 comprising 83 S. prolificans, 33 S. apiospermum, and 30 
S. aurantiacum.
‡More than 1 Scedosporium spp. was isolated from 4 patients. RESEARCH
polymorphisms, PcoA of PCR ﬁ  ngerprint proﬁ  les showed 
dense clustering for S. proliﬁ  cans (Figure 3), which is con-
sistent with the low to absent intraspecies variability in S. 
proliﬁ  cans found by others (20,21,33). These apparently 
contradictory ﬁ  ndings emphasize the importance of choos-
ing the optimum molecular typing tool with the most ap-
propriate discriminatory power for the organism or species 
being studied.
The high degree of intraspecies variation detected by 
PCR ﬁ  ngerprinting and AFLP analysis supports the use of 
these methods to establish genetic relatedness between iso-
lates recovered from different patients or multiple isolates 
from the same patient. In comparison, the variation detect-
ed by ITS-RFLP analysis and ITS sequencing correspond-
ed to interspecies variation, which makes those techniques 
ideal for identiﬁ  cation of any given isolate to the species 
level. Individual patients are most likely infected or colo-
nized with genetically distinct strains (19–21; this study). 
Identical PCR ﬁ  ngerprint or AFLP proﬁ  les were noted in 
multiple isolates recovered simultaneously from differ-
ent anatomic sites in the same patient (21; current study). 
However, 8 patients were infected or colonized by at least 
2 strains as reﬂ  ected by their different genetic proﬁ  les (on-
line Technical Appendix). Possible explanations include 
concomitant infection by multiple strains from which only 
a restricted number were recovered, or colonization by 1 
strain followed by infection or colonization with a second 
strain of a different genotype. Longitudinal genotyping 
studies are required to determine the likelihood that per-
sistence of >1 genotypes later leads to clinically important 
infection or whether the disease is more likely to be caused 
by an unrelated genotype. In this context, the development 
of a multilocus sequence typing scheme for Scedosporium, 
as has been developed for Candida spp. (35), would be of 
great advantage to overcome interlaboratory reproducibil-
ity problems, which are known to be associated with PCR 
ﬁ  ngerprinting or AFLP data. However, developing such a 
scheme remains cumbersome due to the current lack of ge-
nomic data of Scedosporium spp. 
For all 3 Scedosporium spp., there was no clustering 
of strains according to their geographic or body site of ori-
gin or by their ability to cause invasive disease, which is 
in agreement with previous ﬁ  ndings for S. apiospermum 
(20,30) and S. proliﬁ  cans (16,17,21). Of note, no speciﬁ  c 
genotypes were associated with underlying medical condi-
tions or risk factors. Compared with S. apiospermum and S. 
aurantiacum S. proliﬁ  cans was more frequently associated 
with  coincident hospital renovation, and invasive disease, 
had a greater predilection to cause disseminated infection 
and was the predominant species isolated from blood and 
other sterile sites (12–16,36; current study). Our prelimi-
nary observations indicate that the epidemiology and clini-
cal relevance of recovering S. aurantiacum may be similar 
to that of S. apiospermum. S. aurantiacum has been report-
ed to colonize the respiratory tract of at-risk patients (8).
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Figure 3. Three-dimensional presentation of the principal coordinate 
analysis of the PCR ﬁ  ngerprinting data showing 3 distinct clusters 
which correspond to Scedosporium proliﬁ  cans (black dots), S. 
aurantiacum (dark gray dots), and S. apiospermum (light gray 
dots), with S. apiospermum showing the highest genetic variation. 
Figure 4. Three-dimensional presentation of the principal 
coordinate analysis of the combined M13 PCR ﬁ  ngerprinting, 
ampliﬁ  ed fragment length polymorphism (AFLP) primers EcoRI-GT 
and MseI-GT, and AFLP primers EcoRI-TG and MseI-CA data from 
the suspected Sydney and Melbourne case cluster isolates and 23 
other Australian isolates. None of the investigated isolates showed 
any epidemiologic connection except 3 isolates obtained from the 
same patient (nos. 1, 73, 119). Blue dots, Melbourne outbreak 
isolates; pink dot, Melbourne-related isolate; red dots, Sydney 
outbreak isolates; green dots, Sydney-related isolates; yellow dots, 
unrelated Australian isolates. Scedosporium Isolates, Australia
In addition to PCR ﬁ  ngerprinting, we applied AFLP 
analysis to investigate the possibility of 2 case clusters 
caused by S. proliﬁ  cans. AFLP analysis was chosen as an 
independent technique using 2 combinations of selective 
primers (Table 1), which have been previously shown to 
have good discriminatory power for fungal strain differen-
tiation (26). Both techniques, previously used to identify 
outbreak strain clusters in the recent cryptococcosis out-
break on Vancouver Island (37), generated in the current 
situation distinct patterns from all S. proliﬁ  cans isolates 
except serial isolates obtained from the same patient (on-
line Appendix Figures 1, 2). These ﬁ  ndings exclude the oc-
currence of nosocomial outbreaks or any close relationship 
with the nonoutbreak isolates, a result similar to those ob-
tained previously (38). Overall nosocomial acquisition of 
infection has been demonstrated in only 2 instances (16,17). 
Scedosporium spp. have rarely been isolated from hospital 
air or from indoor or outdoor surface samples (13,39,40, 
current study), which raises questions about the mode of 
acquisition by patients and the mechanisms of the selection 
of this speciﬁ  c fungus as an infectious agent from among 
the high biodiversity of environmental molds.
In conclusion, ITS-RFLP analysis is a powerful tool 
for distinguishing between isolates of the new species S. 
aurantiacum and S. apiospermum. PCR ﬁ  ngerprinting and 
AFLP analysis are useful techniques for determining ge-
netic relatedness between Scedosporium isolates and for 
investigating potential case clusters.  
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